Daniel Spasic

Daniel Spasic General Information

Description

Mr. Daniel serves as Executive Advisor at Ampersand Capital Partners. He serves as a Board Member at Avance Clinical. He serves as a Board Member at PathoQuest. He serves as Executive Chairman at Julius Clinical. He serves as a Chairman at Trialbee. He is the Founder and Board Member of TFS International. He served as a Board Member at NuvoAir. He served as a Board Member at Proteros biostructures. He served in the Medical Department in Sweden and Italy working with clinical development in CNS and oncology drug development. In 1996, he founded TFS International. Under his guidance, TFS has become the largest private global clinical CRO serving the pharmaceutical, biotechnological, medical device, and diagnostic companies in their clinical product development process. TFS has affiliate locations throughout Europe, the USA, and Japan, and annual revenues exceed €55 million. He holds a technical degree in chemical engineering. He holds several board seats across the life science industry and is a driven life science entrepreneur, strategist, and growth advisor with 25 years in senior life science executive roles. He founded TFS HealthSciences (TFS) in 1996. He is acting as a board member for a series of Pharma Service companies in Europe and the US. He is representing S-Growth Holdings LLC; a Boston-based family office with an investment focus in Pharma Services. He holds a technical degree in chemical engineering and an OPM from Harvard Business School.